Literature DB >> 16500321

Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.

Miguel A Checa1, María Prat, Ana Robles, Ramón Carreras.   

Abstract

OBJECTIVE: To assess the usefulness of the GnRH antagonist cetrorelix to prevent LH surge and to avoid intrauterine insemination at weekends when a gynecologist on duty is not available and the ultrasound scan on Friday showed > 1 and < 3 follicles > or = 17 mm in diameter.
DESIGN: Open-label, randomized, prospective study.
SETTING: Reproductive medicine unit in an acute care teaching hospital in Barcelona, Spain. PATIENT(S): Infertile patients undergoing controlled ovarian hyperstimulation (COH) and IUI. INTERVENTION(S): Treatment with recombinant FSH was started on day 3. In women assigned to the control group (n = 32), recombinant FSH was continued up to the day of hCG administration. In patients assigned to the GnRH antagonist group (n = 35), half of the dose of recombinant FSH was given for 2 more days in addition to cetrorelix (0.25 mg SC) until the day of hCG administration. MAIN OUTCOME MEASURE(S): Recombinant FSH doses, E(2) level on the day of hCG administration, number and diameter of follicles, endometrial thickness, and number of pregnancies. RESULT(S): Only a case of premature ovulation occurred in the cetrorelix group. There were no significant differences between the study groups in the total mean number of follicles, follicles > 10 mm and < 17 mm, and follicles > or = 17 mm. The mean concentration of E2 on the day of hCG administration and the endometrial thickness were significantly higher in the cetrorelix group. Eleven pregnancies were achieved, 7 (20%) in the cetrorelix group (4 singleton, 3 twins) and 4 (12.5%) in controls (4 singleton). No case of ovarian hyperstimulation syndrome (OHSS) occurred. CONCLUSION(S): The use of cetrorelix to avoid IUI at weekends when the ultrasound scan on Friday shows > 1 and < 3 follicles > or = 17 mm is a useful alternative for medical centers in which a gynecologist on call is not available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500321     DOI: 10.1016/j.fertnstert.2005.08.040

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.

Authors:  Ramazan Dansuk; Ali Ihsan Gonenc; Sinem Sudolmus; Oguz Yucel; Osman Sevket; Nadiye Köroğlu
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

2.  Evaluation of Role of GnRH Antagonist in Intrauterine Insemination (IUI) Cycles with Mild Ovarian Hyperstimulation (MOH): A Prospective Randomised Study.

Authors:  Leena Wadhwa; Rupali Khanna; Taru Gupta; Sangeeta Gupta; Sarika Arora; Sumi Nandwani
Journal:  J Obstet Gynaecol India       Date:  2016-02-26

Review 3.  Effectiveness of GnRH antagonist in the management of subfertile couples undergoing controlled ovarian stimulation and intrauterine insemination: a meta-analysis.

Authors:  Shan Luo; Shangwei Li; Song Jin; Ya Li; Yaoyao Zhang
Journal:  PLoS One       Date:  2014-10-09       Impact factor: 3.240

4.  Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles.

Authors:  Shikha Jain; Abha Majumdar
Journal:  J Hum Reprod Sci       Date:  2016 Jul-Sep

5.  GnRH antagonist administration to postpone a weekend intrauterine insemination: a large cohort study from a public center.

Authors:  J Gobernado; C Alvarez-Colomo; L Rodriguez-Tabernero; L Barrero; J M F Fernández-Gómez; J Schneider
Journal:  Reprod Biol Endocrinol       Date:  2016-09-02       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.